BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 20394835)

  • 1. Knockdown of hTERT and concurrent treatment with interferon-gamma inhibited proliferation and invasion of human glioblastoma cell lines.
    George J; Banik NL; Ray SK
    Int J Biochem Cell Biol; 2010 Jul; 42(7):1164-73. PubMed ID: 20394835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of hTERT knockdown and IFN-gamma treatment inhibited angiogenesis and tumor progression in glioblastoma.
    George J; Banik NL; Ray SK
    Clin Cancer Res; 2009 Dec; 15(23):7186-95. PubMed ID: 19934306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of hTERT by siRNA inhibits cervical cancer cell growth in vitro and in vivo.
    Shi YA; Zhao Q; Zhang LH; Du W; Wang XY; He X; Wu S; Li YL
    Int J Oncol; 2014 Sep; 45(3):1216-24. PubMed ID: 24920549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Butylidenephthalide suppresses human telomerase reverse transcriptase (TERT) in human glioblastomas.
    Lin PC; Lin SZ; Chen YL; Chang JS; Ho LI; Liu PY; Chang LF; Harn YC; Chen SP; Sun LY; Huang PC; Chein JT; Tsai CH; Chou CW; Harn HJ; Chiou TW
    Ann Surg Oncol; 2011 Nov; 18(12):3514-27. PubMed ID: 21553143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IFN-gamma/IRF-1-induced p27kip1 down-regulates telomerase activity and human telomerase reverse transcriptase expression in human cervical cancer.
    Lee SH; Kim JW; Oh SH; Kim YJ; Rho SB; Park K; Park KL; Lee JH
    FEBS Lett; 2005 Feb; 579(5):1027-33. PubMed ID: 15710386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of all-trans retinoic acid and interferon-gamma upregulated p27(kip1) and down regulated CDK2 to cause cell cycle arrest leading to differentiation and apoptosis in human glioblastoma LN18 (PTEN-proficient) and U87MG (PTEN-deficient) cells.
    Zhang R; Banik NL; Ray SK
    Cancer Chemother Pharmacol; 2008 Aug; 62(3):407-16. PubMed ID: 17960384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-138 overexpression is more powerful than hTERT knockdown to potentiate apigenin for apoptosis in neuroblastoma in vitro and in vivo.
    Chakrabarti M; Banik NL; Ray SK
    Exp Cell Res; 2013 Jun; 319(10):1575-85. PubMed ID: 23562653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of taxol and Bcl-2 siRNA induces apoptosis in human glioblastoma cells and inhibits invasion, angiogenesis and tumour growth.
    George J; Banik NL; Ray SK
    J Cell Mol Med; 2009 Oct; 13(10):4205-18. PubMed ID: 19473291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. hTERT-targeted RNA interference inhibits tumorigenicity and motility of HCT116 cells.
    Shen Y; Zhang YW; Zhang ZX; Miao ZH; Ding J
    Cancer Biol Ther; 2008 Feb; 7(2):228-36. PubMed ID: 18059183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of plasmid-mediated RNA interference targeting telomerase reverse transcriptase on lung cancer cells.
    Ge L; Deng Z; Zhang Y; Shao W; Qiu Y; Cui D; Huang D
    Oncol Rep; 2011 Dec; 26(6):1487-95. PubMed ID: 21922145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth arrest in ovarian cancer cells by hTERT inhibition short-hairpin RNA targeting human telomerase reverse transcriptase induces immediate growth inhibition but not necessarily induces apoptosis in ovarian cancer cells.
    Luo Y; Yi Y; Yao Z
    Cancer Invest; 2009 Dec; 27(10):960-70. PubMed ID: 19909010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of human telomerase reverse transcriptase in apoptosis of human umbilical vein endothelial cells induced by trichostatin A].
    Wu P; Xi L; Chen G; Wang BB; Luo DF; Lu YP; Zhou JF; Ma D
    Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):334-7. PubMed ID: 17892126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. hTERT-siRNA could potentiate the cytotoxic effect of gemcitabine to pancreatic cancer cells Bxpc-3.
    Tan J; Zhou X; Zhu H
    Exp Clin Transplant; 2012 Aug; 10(4):386-93. PubMed ID: 22757972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-(4-Hydroxyphenyl)retinamide induced differentiation with repression of telomerase and cell cycle to increase interferon-gamma sensitivity for apoptosis in human glioblastoma cells.
    Janardhanan R; Banik NL; Ray SK
    Cancer Lett; 2008 Mar; 261(1):26-36. PubMed ID: 18164543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of FRAT1 expression by RNA interference inhibits human glioblastoma cell growth, migration and invasion.
    Guo G; Kuai D; Cai S; Xue N; Liu Y; Hao J; Fan Y; Jin J; Mao X; Liu B; Zhong C; Zhang X; Yue Y; Liu X; Ma N; Guo Y
    PLoS One; 2013; 8(4):e61206. PubMed ID: 23613813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
    Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP
    Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential hTERT knockdown and apigenin treatment inhibited invasion and proliferation and induced apoptosis in human malignant neuroblastoma SK-N-DZ and SK-N-BE2 cells.
    Chakrabarti M; Banik NL; Ray SK
    J Mol Neurosci; 2013 Sep; 51(1):187-98. PubMed ID: 23417743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of combined siRNA-TR and -TERT on telomerase activity and growth of bladder transitional cell cancer BIU-87 cells.
    Cheng W; Wei Z; Gao J; Zhang Z; Ge J; Jing K; Xu F; Xie P
    J Huazhong Univ Sci Technolog Med Sci; 2010 Jun; 30(3):391-6. PubMed ID: 20556588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of hTERT and Cyclin D1 transcription via PI3K/Akt and TGF-β pathways in MCF-7 Cancer cells with PX-866 and Raloxifene.
    Peek GW; Tollefsbol TO
    Exp Cell Res; 2016 May; 344(1):95-102. PubMed ID: 27017931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing of hTERT blocks growth and migration of anaplastic thyroid cancer cells.
    Maggisano V; Celano M; Lombardo GE; Lepore SM; Sponziello M; Rosignolo F; Verrienti A; Baldan F; Puxeddu E; Durante C; Filetti S; Damante G; Russo D; Bulotta S
    Mol Cell Endocrinol; 2017 Jun; 448():34-40. PubMed ID: 28288903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.